TIMBER PHARMACEUTICALS INC (TMBR) Stock Analyst Ratings
USA - NYSEARCA:TMBR - US8870802084 - Common Stock
0.3426 USD
+0 (+0.74%)
0.3532 USD
+0.01 (+3.09%)
ChartMill assigns a Buy % Consensus number of 43% to TMBR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.22. This target is 3174.96% above the current price.
TMBR was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TMBR.
In the previous month the buy percentage consensus was at a similar level.
TMBR was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-28 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-04-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-26 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-29 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-02 | HC Wainwright & Co. | Maintains | Buy |
TIMBER PHARMACEUTICALS INC / TMBR FAQ
What do analysts expect the price target to be for TIMBER PHARMACEUTICALS INC (TMBR)?
6 analysts have analysed TMBR and the average price target is 11.22 USD. This implies a price increase of 3174.96% is expected in the next year compared to the current price of 0.3426.
What is the consensus rating for TIMBER PHARMACEUTICALS INC (TMBR) stock?
The consensus rating for TIMBER PHARMACEUTICALS INC (TMBR) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.